Koers Winston Pharmaceuticals, Inc. Other OTC
Aandelen
WPHM
US9756571074
Farmaceutische producten
Omzet 2008 | 453K 422K | Omzet 2009 | 1,39 mln. 1,3 mln. | Marktkapitalisatie | 21,67 mln. 20,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2008 | -5 mln. -4,66 mln. | Nettowinst (verlies) 2009 | -2 mln. -1,87 mln. | EV/omzet 2008 | 572 x |
Nettoliquiditeiten 2008 | 5,63 mln. 5,25 mln. | Nettoliquiditeiten 2009 | 1,56 mln. 1,46 mln. | EV/omzet 2009 | 14,4 x |
K/w-verhouding 2008 |
-49,9
x | K/w-verhouding 2009 |
-6,46
x | Werknemers | - |
Dividendrendement 2008 * |
-
| Dividendrendement 2009 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 81 | 01-01-92 | |
Director of Finance/CFO | 57 | - | |
Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 81 | 01-01-92 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,99% | 798 mld. | |
-5,72% | 356 mld. | |
+18,94% | 328 mld. | |
+11,07% | 304 mld. | |
+16,96% | 244 mld. | |
+2,25% | 227 mld. | |
+11,15% | 216 mld. | |
+7,59% | 166 mld. | |
-3,65% | 157 mld. |